SCHEMBL3967536

SCHEMBL3967536

CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)c2ccc(C#N)cc2)no1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)c2cccnc2)no1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)c2ccsc2)no1.CC(C)(C)c1csc(NC(=O)C(C)(C)S(=O)(=O)c2cccnc2)n1.COc1ccc(S(=O)(=O)C(C)(C)C(=O)Nc2cc(C(C)(C)C)on2)cc1F

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.40
CNR1 P21554 3/20 0.40
NAMPT P43490 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
FLT3 P36888 5/20 0.33
MAPK1 P28482 1/20 0.32
CTPS1 P17812 1/20 0.32
ALPL P05186 1/20 0.32
BRAF P15056 2/20 0.31
NTRK1 P04629 1/20 0.31
RET P07949 1/20 0.31
RAF1 P04049 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3962771 0.88 CNR2 (0.51) CNR2CNR1FLT3BRAFRAF1
SCHEMBL1465008 0.75 CNR2 (0.66) CNR2CNR1SMN1; SMN2FLT3BRAF
SCHEMBL1465065 0.71 SMN1; SMN2 (0.52) SMN1; SMN2MAPK1CTPS1
SCHEMBL1464597 0.71 CNR2 (0.67) CNR2CNR1SMN1; SMN2FLT3RAF1
SCHEMBL1464614 0.71 CNR2 (0.73) CNR2CNR1SMN1; SMN2
SCHEMBL3960143 0.71 CNR2 (0.52) CNR2CNR1SMN1; SMN2FLT3MAPK1
SCHEMBL1464387 0.71 CNR2 (0.68) CNR2CNR1SMN1; SMN2
SCHEMBL3963557 0.70 CNR2 (0.56) CNR2CNR1SMN1; SMN2FLT3MAPK1
SCHEMBL3963555 0.69 CNR2 (0.55) CNR2CNR1SMN1; SMN2FLT3MAPK1
SCHEMBL3963097 0.68 CNR2 (0.54) CNR2CNR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP disclosed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO disclosed